Lets Talk Finances

Provoking Discussion on Personal Finance and Investing

MXCT - MaxCyte, Inc. ()

Overview

Company Summary


MaxCyte, Inc. is a leading global cell-based therapies and life sciences company. They combine expertise in cell engineering with proprietary electroporation delivery technology to enable the discovery, development, manufacturing, and commercialization of advanced, next-generation cell therapies.

MaxCyte offers a unique platform called MaxCyte GT�, which allows precise modification of cells using their Flow Electroporation� technology. This platform is designed to deliver high-quality, high-performance therapies across a range of applications, including gene editing, immuno-oncology, and regenerative medicine.

The company collaborates with leading pharmaceutical and biotechnology companies, research institutions, and academic centers to develop novel therapies that can potentially address a wide array of diseases with significant unmet medical needs. Their technology allows for improved targeting and precision in delivering therapeutic treatments using a broad range of cell types.

In addition, MaxCyte provides contract development and manufacturing organization (CDMO) services to support the production of cell-based therapies. They offer support through all stages of development, from early research to preclinical and clinical studies, and ultimately to commercial manufacturing.

MaxCyte's novel approach to cell engineering and therapy development positions them at the forefront of the rapidly growing field of cell-based therapies, which hold immense potential for revolutionizing the treatment of various diseases and conditions.

Notes (see all)

News